Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-HLNILSTLWKYR-NH2
3D-Ansicht

Biosynth logo

H-HLNILSTLWKYR-NH2

Ref. 3D-PP46163

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 10. Dezember 2024

Produktinformation

Name:
H-HLNILSTLWKYR-NH2
Synonyme:
  • NH2-His-Leu-Asn-Ile-Leu-Ser-Thr-Leu-Trp-Lys-Tyr-Arg-amide
Beschreibung:

Peptide H-HLNILSTLWKYR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-HLNILSTLWKYR-NH2 include the following: Targeted delivery of Tet1 peptide functionalized polymersomes to the rat cochlear nerve Y Zhang, W Zhang, AH Johnston - International journal , 2012 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S28185 Applications of Nanoparticles in Alzheimer's Disease Y Liu, Y Shen - Journal of Alzheimer's Disease, 2023 - content.iospress.comhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad230098 Tet1 peptide and zinc (II)-adenine multifunctional module functionalized polycations as efficient siRNA carriers for Parkinson's disease W Liu, C Ma, J Cao, H Zhou, T Guo - Journal of Controlled Release, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365924000579 A means for targeting therapeutics to peripheral nervous system neurons with axonal damage T Federici, JK Liu , Q Teng, J Yang, NM Boulis - Neurosurgery, 2007 - journals.lww.comhttps://journals.lww.com/neurosurgery/fulltext/2007/05000/Bovine_Pericardium_for_Dural_Grafts__Clinical.15.aspx Non-viral carriers for nucleic acids delivery: Fundamentals and current applications S Shtykalova , D Deviatkin, S Freund, A Egorova - Life, 2023 - mdpi.comhttps://www.mdpi.com/2075-1729/13/4/903 "œCascaded Rocket" Nanosystems with Spatiotemporal Separation for Triple-Synergistic Therapy of Alzheimer's Disease R Liu , J Yang, X Qiu, W Ji, J Shen, Y Li - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101748 Poly-Lactide/Poly-Lactide-co-Glycolide-Based Delivery System for Bioactive Compounds against Microbes R Kumar , D Jha , AK Panda - Pharmaceuticals from Microbes: The , 2019 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-01881-8_3 Diagnostic and therapeutic potential of tetanus toxin-derivatives in neurological diseases R Kassa, V Monterroso, LL David - Journal of Molecular , 2013 - Springerhttps://link.springer.com/article/10.1007/s12031-013-0065-x Development of peptide targeted PLGA-PEGylated nanoparticles loading licochalcone-A for ocular inflammation R Galindo, E Sanchez-Lopez, MJ Gomara, M Espina - Pharmaceutics, 2022 - mdpi.comhttps://www.mdpi.com/1999-4923/14/2/285 Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Abeta40 plaques in Alzheimer's PC Bhatt, A Verma , FA Al-Abbasi , F Anwar - International journal , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S144545 Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease P Wang, X Zheng, Q Guo, P Yang, X Pang - Journal of controlled , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918302190 Therapeutic and diagnostic applications of nanocomposites in the treatment Alzheimer's disease studies M Pathak , R Singhal - Biointerface Research in Applied , 2022 - biointerfaceresearch.comhttps://biointerfaceresearch.com/wp-content/uploads/2021/04/20695837121.940960.pdf Polymeric nanoparticles properties and brain delivery L Ribovski , NM Hamelmann , JMJ Paulusse - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/12/2045 Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer's disease L Del Amo, A Cano , M Ettcheto, EB Souto , M Espina - Applied sciences, 2021 - mdpi.comhttps://www.mdpi.com/2076-3417/11/9/4305 Polymeric nanoparticles as a vehicle for delivery of antioxidants in the brain: Potential application in neurodegenerative diseases JM Rabanel , G Djiokeng-Paka - Biomedical Application , 2017 - taylorfrancis.comhttps://www.taylorfrancis.com/chapters/edit/10.1201/9781315152363-12/polymeric-nanoparticles-vehicle-delivery-antioxidants-brain-jean-michel-rabanel-ghislain-djiokeng-paka-charles-ramassamy Nucleic-acid based Structures as Smart Nanotools in Neurotherapeutics JAV da Silva - 2016 - repositorio-aberto.up.pthttps://repositorio-aberto.up.pt/bitstream/10216/94251/2/157485.pdf Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-beta aggregation and cytotoxicity J Zhang, X Zhou, Q Yu, L Yang, D Sun - applied materials & , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/am501341u Conjugation, prodrug, and co-administration strategies in support of nanotechnologies to improve the therapeutic efficacy of phytochemicals in the central nervous G Rassu , M Sorrenti, L Catenacci, B Pavan , L Ferraro - Pharmaceutics, 2023 - mdpi.comhttps://www.mdpi.com/1999-4923/15/6/1578 Rational design of siRNA-based delivery systems for effective treatment of brain diseases D Lu, Y Sun, Y Luan, W He - Pharmaceutical Science Advances, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2773216924000072 Tetanus toxin fragment C: structure, drug discovery research and production C Bayart , A Mularoni, N Hemmani , S Kerachni, J Jose - Pharmaceuticals, 2022 - mdpi.comhttps://www.mdpi.com/1424-8247/15/6/756 Overcoming barriers in non-viral gene delivery for neurological applications A Tasset, A Bellamkonda, W Wang , I Pyatnitskiy - Nanoscale, 2022 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2022/nr/d1nr06939j Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease A Mathew, T Fukuda, Y Nagaoka, T Hasumura - PLoS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0032616

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP46163 H-HLNILSTLWKYR-NH2

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.